What is Eikon Therapeutics, Inc. 's shares (diluted)?

Eikon Therapeutics, Inc. (EIKN) reported shares (diluted) of 33.7M in Q1 2026.

What does shares (diluted) mean?

The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Eikon Therapeutics, Inc. EIKN Shares (Diluted)

Shares (Diluted) at other companies

MYR GroupMYRG

15.7M-2.4%

Cabot CorporationCBT

52.2M-4.0%

HES

Hess MidstreamHESM

129.2M+16.6%

Main Street CapitalMAIN

90.7M+2.2%

BeldenBDC

39.4M-3.5%

UnifirstUNF

18.1M-2.7%

Other financials

Income statement

See full

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Balance sheet

See full

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Cash flow

See full

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Valuation

See full

Market cap$521.35M—

Where this comes from

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eikon Therapeutics, Inc. 's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eikon Therapeutics, Inc. 's shares (diluted)?: Eikon Therapeutics, Inc. (EIKN) reported shares (diluted) of 33.7M in Q1 2026.
What does shares (diluted) mean?: The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.